339 related articles for article (PubMed ID: 21161390)
21. Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.
Jaiswal PK; Singh V; Mittal RD
Mol Biol Rep; 2014 Feb; 41(2):799-807. PubMed ID: 24390231
[TBL] [Abstract][Full Text] [Related]
22. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
[TBL] [Abstract][Full Text] [Related]
23. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population.
Zhang PA; Wu JM; Li Y; Yang XS
World J Gastroenterol; 2005 Mar; 11(11):1594-8. PubMed ID: 15786533
[TBL] [Abstract][Full Text] [Related]
24. T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis.
Chang MC; Chang YT; Tien YW; Liang PC; Jan IS; Wei SC; Wong JM
Clin Chem; 2007 Sep; 53(9):1700-5. PubMed ID: 17712006
[TBL] [Abstract][Full Text] [Related]
25. CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch-Schönlein purpura.
Wang JJ; Shi YP; Yue H; Chun W; Zou LP
Pediatr Nephrol; 2012 Nov; 27(11):2059-2064. PubMed ID: 22700162
[TBL] [Abstract][Full Text] [Related]
26. Association of cytotoxic T-lymphocyte antigen-4 + 49A/G gene polymorphism with hepatocellular carcinoma risk in Chinese.
Wang C; Liu W; Zhao L; Dong Z
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1117-S1120. PubMed ID: 30539855
[TBL] [Abstract][Full Text] [Related]
27. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
[TBL] [Abstract][Full Text] [Related]
28. Correlations of CTLA-4 exon-1 49 A/G and promoter region 318C/T polymorphisms with the therapeutic efficacy of
Han XR; Wen X; Wang S; Fan SH; Zhuang J; Wang YJ; Zhang ZF; Li MQ; Hu B; Shan Q; Sun CH; Bao YX; Wu DM; Lu J; Zheng YL
J Cell Biochem; 2018 Aug; 119(8):6383-6390. PubMed ID: 28776731
[TBL] [Abstract][Full Text] [Related]
29. Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population.
Zhang X; Zhai L; Rong C; Qin X; Li S
PLoS One; 2015; 10(11):e0143069. PubMed ID: 26599409
[TBL] [Abstract][Full Text] [Related]
30. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population.
Wang L; Li D; Fu Z; Li H; Jiang W; Li D
BMC Cancer; 2007 Sep; 7():173. PubMed ID: 17825114
[TBL] [Abstract][Full Text] [Related]
31. Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population.
Du T; Guo XH; Zhu XL; Li JH; Lu LP; Gao JR; Gou CY; Li Z; Liu Y; Li H
J Viral Hepat; 2006 Sep; 13(9):618-24. PubMed ID: 16907849
[TBL] [Abstract][Full Text] [Related]
32. CTLA-4 +49A/G Polymorphism Increases the Susceptibility to Bladder Cancer in Chinese Han Participants: A Case-Control Study.
Mao F; Niu XB; Gu S; Ji L; Wei BJ; Wang HB
Dis Markers; 2020; 2020():8143158. PubMed ID: 33335608
[TBL] [Abstract][Full Text] [Related]
33. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population.
Li W; Jiang Y; Jin Q; Shi X; Jin J; Gao Y; Pan Y; Zhang H; Jiang J; Niu J
Liver Int; 2011 Sep; 31(8):1118-26. PubMed ID: 21745278
[TBL] [Abstract][Full Text] [Related]
34. A promoter polymorphism (rs3806798) of interleukin-15 gene is associated with chronic hepatitis B virus infection in the Chinese Han population.
Zhang X; Sun XH; Li M; Zhou ZH; Gao YQ
Int J Immunogenet; 2014 Aug; 41(4):298-305. PubMed ID: 24762213
[TBL] [Abstract][Full Text] [Related]
35. [Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-related hepatocellular carcinoma in Hunan Han population].
Liu G; Lu GX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1838-40. PubMed ID: 20813679
[TBL] [Abstract][Full Text] [Related]
36. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
[TBL] [Abstract][Full Text] [Related]
37. Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk.
Wang L; Su G; Zhao X; Cai Y; Cai X; Zhang J; Liu J; Wang T; Wang J
Tumour Biol; 2014 Feb; 35(2):1139-42. PubMed ID: 24014088
[TBL] [Abstract][Full Text] [Related]
38. Relationship between interleukin-6 polymorphism and susceptibility to chronic hepatitis B virus infection.
Zhao XM; Gao YF; Zhou Q; Pan FM; Li X
World J Gastroenterol; 2013 Oct; 19(40):6888-93. PubMed ID: 24187466
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
